October 2016, 24:7

15 November 2016

Original Paper

Original Paper

2015 Clinical Practice Guidelines for the Management of Dyslipidemia in the Philippines - Executive Summary

Dyslipidemia Guidelines 2015

Adriel E. Guerrero

ASEAN Heart Journal

First online: 

  • Facebook Social Icon
  • Twitter Social Icon
  • Google+ Social Icon

Reference Tools

Abstract

​​​

The Philippine Heart Association, the Philippine Lipid and Atherosclerosis Society, and the Philippine Society of Endocrinology, Diabetes, and Metabolism, collaborated to develop the 2015 Clinical Practice Guidelines for the Management of Dyslipidemia in the Philippines (2015 CPG). These guidelines are meant to update the 2005 Clinical Practice Guidelines on the Management of Dyslipidemia in the Philippines (2005 CPG). A panel of experts in the fields of dyslipidemia, cardiology, endocrinology and epidemiology were assembled to comprise the technical research committee (TRC) tasked to review available clinical evidence on dyslipidemia management. The main objective for this document is to develop clinical guidelines in the management of Filipino patients who are diagnosed with elevated cholesterol. This may infl uence standards and national policies for optimal patient care and cardiovascular health.

Keywords

Statin Therapy - Ezetimibe - Clinical Question - Familial Hypercholesterolemia - Familial Hypercholesterolemia

___________________________________________________________________________________________

©Philippine Heart Association, Inc. and Philippine College of Cardiology. This article is published with Open Access by ASEAN Federation of Cardiology.

Correspondence: Adriel E. Guerrero, MD, Philippine Heart Association, Council on Preventive Cardiology. Email: boyingmd2004@yahoo.com

.

.

Tel No: +603-7931 7900
Fax No: +603-7932 1400

 

 

D-13A-06, Menara Suezcap 1, KL Gateway,
No.2 Jalan Kerinchi, Gerbang Kerinchi Lestari,
59200 Kuala Lumpur, Malaysia.

www.aseancardiology.org

ASEAN HEART Journal is Supported by Unrestricted Grant From 

Committed to therapeutic advances in cardiovascular research